Form 8-K GILEAD SCIENCES, INC. For: Apr 25
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Gilead Sciences (GILD) PT Lowered to $76 at Barclays
April 29, 2024 5:23 AM EDTBarclays analyst Carter Gould lowered the price target on Gilead Sciences (NASDAQ: GILD) to $76.00 (from $80.00) while maintaining a Equalweight rating.
The analyst comments "'25 HIV zero-growth messaging, puts onus on cell therapy and seladelpar launch to deliver overall top-line growth. Focus... More
